Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

22.40
-0.1400-0.62%
Post-market: 22.25-0.1500-0.67%17:20 EDT
Volume:1.57M
Turnover:35.52M
Market Cap:1.04B
PE:-9.87
High:24.00
Open:22.25
Low:21.74
Close:22.54
Loading ...

Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency

TIPRANKS
·
10 Jul

Pacira Biosciences Inc. Announces Reorganization, Shuts Down 45-Liter Facility, Reduces Workforce by 70

Reuters
·
10 Jul

Pacira Pharmaceuticals Secures New $300M Credit Facility

TIPRANKS
·
07 Jul

Pacira BioSciences Inc. Secures $300 Million Credit Agreement with Wells Fargo and Lenders, Refinances Existing Debt

Reuters
·
07 Jul

RBC Capital Sticks to Their Hold Rating for Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
07 Jul

U.S. RESEARCH ROUNDUP-Analog Devices, Constellation Brands, Phibro Animal Health

Reuters
·
07 Jul

BRIEF-Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Jul

Pacira BioSciences Announces Inducement Grants Under Amended 2014 Plan for New Employees

Reuters
·
04 Jul

Pacira debuts film spotlighting patient journey to pain relief

TIPRANKS
·
18 Jun

Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan

TIPRANKS
·
14 Jun

Pacira Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
14 Jun

Pacira BioSciences Announces Promising Three-Year Data on Gene Therapy PCRX-201 for Osteoarthritis of the Knee

Reuters
·
11 Jun

Lauren Riker, Senior Vice President of Finance, Reports Disposal of Common Shares of Pacira Biosciences Inc

Reuters
·
06 Jun

Kristen Williams, Chief Administrative Officer, Reports Disposal of Common Shares of Pacira Biosciences Inc

Reuters
·
06 Jun

Pacira BioSciences Announces Inducement Grants for New Employees Under Amended 2014 Plan

Reuters
·
05 Jun

Pacira Biosciences Announces Promising Preliminary Results for Gene Therapy PCRX-201 in Treating Osteoarthritis Knee Pain

Reuters
·
15 May

Pacira BioSciences Inc. to Participate in Analyst-Led Fireside Chat at RBC Capital Markets Global Healthcare Conference

Reuters
·
14 May

Stock Track | Pacira Pharmaceuticals Plummets 7.67% as Q1 Revenue Falls Short of Analyst Expectations

Stock Track
·
09 May

Pacira BioSciences Is Maintained at Buy by Needham

Dow Jones
·
09 May

Pacira Q1 Adjusted Earnings Unchanged; Revenue Rises; 2025 Sales Guidance Steady

MT Newswires Live
·
09 May